Kato N - Search Results

1

[Recent progress and prospective view of chronic hepatitis C research].

Otsuka M, Kato N, Omata M. Otsuka M, et al. Among authors: kato n. Nihon Rinsho. 2001 Jul;59(7):1243-7. Nihon Rinsho. 2001. PMID: 11494531 Review. Japanese.

2

How soon can a virological sustained response be determined after withdrawal of interferon therapy in chronic hepatitis C? Tokyo-Chiba Hepatitis Research Group.

Shiratori Y, Kato N, Yoshida H, Imazeki F, Okano K, Yokosuka O, Omata M. Shiratori Y, et al. Among authors: kato n. J Gastroenterol Hepatol. 1999 Jan;14(1):79-84. doi: 10.1046/j.1440-1746.1999.01802.x. J Gastroenterol Hepatol. 1999. PMID: 10029282

3

[HCV proteins suppress translation].

Kato J, Kato N, Shiratori Y, Omata M. Kato J, et al. Among authors: kato n. Nihon Rinsho. 2001 Jul;59(7):1254-8. Nihon Rinsho. 2001. PMID: 11494533 Review. Japanese.

4

Recent advances in hepatitis C virus research.

Omata M, Kato N. Omata M, et al. Among authors: kato n. J Gastroenterol. 1994 Jun;29(3):377-82. doi: 10.1007/BF02358381. J Gastroenterol. 1994. PMID: 8061810 Review. No abstract available.

5

[Future perspectives of molecular hepatology].

Omata M, Kato N. Omata M, et al. Among authors: kato n. Nihon Rinsho. 1993 Feb;51(2):263-6. Nihon Rinsho. 1993. PMID: 8385233 Review. Japanese. No abstract available.

6

Real-time monitoring of HCV-RNA by single tube assay kit and potential importance for predicting virological sustained response in patients with chronic hepatitis C.

Shiratori Y, Kato N, Tamatsukuri S, Yoshida H, Kawabe T, Nakata R, Okano K, Omata M. Shiratori Y, et al. Among authors: kato n. J Gastroenterol Hepatol. 1996 Aug;11(8):705-11. doi: 10.1111/j.1440-1746.1996.tb00318.x. J Gastroenterol Hepatol. 1996. PMID: 8872765

7

Predictors of the efficacy of interferon therapy in chronic hepatitis C virus infection. Tokyo-Chiba Hepatitis Research Group.

Shiratori Y, Kato N, Yokosuka O, Imazeki F, Hashimoto E, Hayashi N, Nakamura A, Asada M, Kuroda H, Tanaka N, Arakawa Y, Omata M. Shiratori Y, et al. Among authors: kato n. Gastroenterology. 1997 Aug;113(2):558-66. doi: 10.1053/gast.1997.v113.pm9247476. Gastroenterology. 1997. PMID: 9247476 Clinical Trial.

8

Quantitative assays for hepatitis C virus in serum as predictors of the long-term response to interferon.

Shiratori Y, Kato N, Yokosuka O, Hashimoto E, Hayashi N, Nakamura A, Asada M, Kuroda H, Ohkubo H, Arakawa Y, Iwama A, Omata M. Shiratori Y, et al. Among authors: kato n. J Hepatol. 1997 Sep;27(3):437-44. doi: 10.1016/s0168-8278(97)80346-7. J Hepatol. 1997. PMID: 9314119

9

Hepatitis C virus nonstructural region 5A protein is a potent transcriptional activator.

Kato N, Lan KH, Ono-Nita SK, Shiratori Y, Omata M. Kato N, et al. J Virol. 1997 Nov;71(11):8856-9. doi: 10.1128/JVI.71.11.8856-8859.1997. J Virol. 1997. PMID: 9343247 Free PMC article.

10

Does dual infection by hepatitis B and C viruses play an important role in the pathogenesis of hepatocellular carcinoma in Japan?

Shiratori Y, Shiina S, Zhang PY, Ohno E, Okudaira T, Payawal DA, Ono-Nita SK, Imamura M, Kato N, Omata M. Shiratori Y, et al. Among authors: kato n. Cancer. 1997 Dec 1;80(11):2060-7. Cancer. 1997. PMID: 9392327

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,930 results

Search Page

Filters